Funding

Turn ideas into impact

Viewing all 37 opportunities
Filter Options
37 results :
Filter List
Close
Update Filters
1
Type
Amount
Source
Eligibility
Status
View 37 Results
Clear All Filters

Due: November 7, 2025

Closing Soon

Tuberculosis Research Units (P01 Clinical Trial Optional)

Type

Grant

Source

Federal

Opp Number

RFA-AI-25-027

Due: November 7, 2025

Closing Soon

Region 3 Fiscal Year 2025 Wetland Program Development Grants

US $160,000

Type

Cooperative Agreement

Source

Federal

Opp Number

EPA-REG3-WPDG-25

Due: November 7, 2025

Closing Soon

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)

Type

Cooperative Agreement

Source

Federal

Opp Number

RFA-AI-25-013

Due: November 7, 2025

Closing Soon

FY 2025 Regional Technology and Innovation Hub Program Notice of Funding Opportunity (NOFO)

US $1 – $100,000,000

Type

Grant

Source

Federal

Opp Number

EDA-TECHHUBS-2025

Due: November 7, 2025

Closing Soon

Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)

US $2,000,000

Type

Cooperative Agreement

Source

Federal

Opp Number

RFA-AI-25-012

Due: November 9, 2025

Closing Soon

AHRQ Mentored Research Scientist Career Development Award (K01)

Type

Grant

Source

Federal

Opp Number

PA-22-255

Due: November 10, 2025

Closing Soon

NIH Blueprint for Neuroscience: Coordination Center for Interoception Research (BPCCIR) (U24, Clinical Trial Not Allowed)

Type

Cooperative Agreement

Source

Federal

Opp Number

RFA-AT-25-004

Due: November 10, 2025

Closing Soon

Service Area Competition

US $181,000,000

Type

Grant

Source

Federal

Opp Number

HRSA-26-006

Due: November 10, 2025

Closing Soon

Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional)

Type

Cooperative Agreement

Source

Federal

Opp Number

RFA-HL-26-006

Submit your funding opportunity.

Do you have a grant, incentive, funding competition, or other funding source to share?

Next up:

Facilities